These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
354 related articles for article (PubMed ID: 36419650)
21. Pan J; Huang Z; Zhang Y; Xu Y DNA Cell Biol; 2022 Apr; 41(4):410-423. PubMed ID: 35377217 [TBL] [Abstract][Full Text] [Related]
22. Prognostic value of S1PR1 and its correlation with immune infiltrates in breast and lung cancers. Zhong L; Xie L; Yang Z; Li L; Song S; Cao D; Liu Y BMC Cancer; 2020 Aug; 20(1):766. PubMed ID: 32799825 [TBL] [Abstract][Full Text] [Related]
23. GRAP2 is a prognostic biomarker and correlated with immune infiltration in lung adenocarcinoma. Song S; Deng X; Jiang S; Tian C; Han J; Chai J; Li N; Yan Y; Luo Z J Clin Lab Anal; 2022 Nov; 36(11):e24662. PubMed ID: 36181310 [TBL] [Abstract][Full Text] [Related]
24. TRAIP serves as a potential prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma. Jing Y; Mao Z; Zhu J; Ma X; Liu H; Chen F Int Immunopharmacol; 2023 Sep; 122():110605. PubMed ID: 37451021 [TBL] [Abstract][Full Text] [Related]
25. Membrane tension sensing molecule-FNBP1 is a prognostic biomarker related to immune infiltration in BRCA, LUAD and STAD. Wang Z; Tian Z; Song X; Zhang J BMC Immunol; 2022 Jan; 23(1):1. PubMed ID: 34998385 [TBL] [Abstract][Full Text] [Related]
26. STARD12/14 are diagnostic and prognostic biomarkers of lung adenocarcinoma associated with epigenetic regulation, immune infiltration and ferroptosis. Zhang WD; Hu DM; Shi ZE; Wang QX; Zhang MY; Liu JY; Ji XL; Qu YQ Int J Med Sci; 2023; 20(11):1427-1447. PubMed ID: 37790851 [No Abstract] [Full Text] [Related]
27. Pan-cancer analysis reveals the relationship between RCSD1 immune infiltration and clinical prognosis in human tumors. Qiao H; Yin H; Feng Y; Tang H Front Immunol; 2022; 13():1008778. PubMed ID: 36311703 [TBL] [Abstract][Full Text] [Related]
28. Increased expression of TTC21A in lung adenocarcinoma infers favorable prognosis and high immune infiltrating level. Wang W; Ren S; Wang Z; Zhang C; Huang J Int Immunopharmacol; 2020 Jan; 78():106077. PubMed ID: 31812070 [TBL] [Abstract][Full Text] [Related]
29. Zhang XZ; Chen MJ; Fan PM; Jiang W; Liang SX Int J Gen Med; 2022; 15():2727-2745. PubMed ID: 35300128 [TBL] [Abstract][Full Text] [Related]
30. Junctional Adhesion Molecule-Like Protein (JAML) Is Correlated with Prognosis and Immune Infiltrates in Lung Adenocarcinoma. Fang L; Yu W; Yu G; Zhong F; Ye B Med Sci Monit; 2022 Jan; 28():e933503. PubMed ID: 35034089 [TBL] [Abstract][Full Text] [Related]
31. NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis. Liu XS; Zhou LM; Yuan LL; Gao Y; Kui XY; Liu XY; Pei ZJ Front Immunol; 2021; 12():724741. PubMed ID: 34335635 [TBL] [Abstract][Full Text] [Related]
32. The EMT-Related Genes GALNT3 and OAS1 are Associated with Immune Cell Infiltration and Poor Prognosis in Lung Adenocarcinoma. Luo D; Fang M; Shao L; Wang J; Liang Y; Chen M; Gui X; Yan J; Wang W; Yu L; Fan X; Wu Q Front Biosci (Landmark Ed); 2023 Oct; 28(10):271. PubMed ID: 37919050 [TBL] [Abstract][Full Text] [Related]
33. High expression of PTGES3 is an independent predictive poor prognostic biomarker and correlates with immune infiltrates in lung adenocarcinoma. Gao P; Zou K; Xiao L; Zhou H; Xu X; Zeng Z; Zhang W Int Immunopharmacol; 2022 Sep; 110():108954. PubMed ID: 35820363 [TBL] [Abstract][Full Text] [Related]
34. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma. Ma C; Kang W; Yu L; Yang Z; Ding T Front Oncol; 2020; 10():590006. PubMed ID: 33363020 [TBL] [Abstract][Full Text] [Related]
35. Identification and prognostic biomarkers among ZDHHC4/12/18/24, and APT2 in lung adenocarcinoma. Bian J; Xiong W; Yang Z; Li M; Song D; Zhang Y; Liu C Sci Rep; 2024 Jan; 14(1):522. PubMed ID: 38177255 [TBL] [Abstract][Full Text] [Related]
36. SLC2A5 Correlated with Immune Infiltration: A Candidate Diagnostic and Prognostic Biomarker for Lung Adenocarcinoma. Luo L; Su J; Zheng Y; Huang F; Huang R; Luo H J Immunol Res; 2021; 2021():9938397. PubMed ID: 34604392 [TBL] [Abstract][Full Text] [Related]
37. ADAR1 is a prognostic biomarker and is correlated with immune infiltration in lung adenocarcinoma. Yang W; Chen K; Yu Q; Liao R; He H; Peng Y; Yang Z; Zhang X Cancer Med; 2023 Jul; 12(13):14820-14832. PubMed ID: 37162299 [TBL] [Abstract][Full Text] [Related]
38. TMPRSS2 Serves as a Prognostic Biomarker and Correlated With Immune Infiltrates in Breast Invasive Cancer and Lung Adenocarcinoma. Xiao X; Shan H; Niu Y; Wang P; Li D; Zhang Y; Wang J; Wu Y; Jiang H Front Mol Biosci; 2022; 9():647826. PubMed ID: 35558557 [TBL] [Abstract][Full Text] [Related]
39. [The Expression of RTN1 in Lung Adenocarcinoma and Its Effect on Immune Microenvironment]. Zhu S; Zu L; Xu S Zhongguo Fei Ai Za Zhi; 2022 Jun; 25(6):385-395. PubMed ID: 35747917 [TBL] [Abstract][Full Text] [Related]
40. ZC3H12D is a prognostic biomarker associated with immune cell infiltration in lung adenocarcinoma. Gong W; Dai W; Wei H; Chen Y; Zheng Z Transl Cancer Res; 2020 Oct; 9(10):6128-6142. PubMed ID: 35117224 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]